C Botti Selected Research

C Botti Research Topics

Disease

15	Neoplasms (Cancer) 07/2012 - 03/2000
15	Breast Neoplasms (Breast Cancer) 07/2012 - 03/2000
4	Sarcoma (Soft Tissue Sarcoma) 03/2009 - 12/2003
4	Hyperthermia 05/2005 - 07/2003
3	Chronic Limb-Threatening Ischemia 01/2013 - 11/2008
3	Peripheral Arterial Disease 09/2012 - 11/2008
3	Melanoma (Melanoma, Malignant) 03/2009 - 12/2003
3	Neoplasm Metastasis (Metastasis) 03/2009 - 07/2001
2	Cardiotoxicity 11/2008 - 11/2008
2	Lung Neoplasms (Lung Cancer) 03/2001 - 10/2000
1	Deglutition Disorders (Dysphagia) 01/2022
1	Mouth Neoplasms (Oral Cancer) 12/2020
1	Disease Progression 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2012
1	Inflammation (Inflammations) 01/2012
1	Chronic Disease (Chronic Diseases) 01/2012
1	Chromosome Deletion (Deletion, Chromosome) 01/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2011
1	Trisomy (Trisomies) 01/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2008
1	Breast Diseases (Breast Disease) 07/2001
1	Polyploidy 05/2001
1	Papillomavirus Infections 05/2001
1	Aneuploidy (Aneuploid) 05/2001
1	Squamous Intraepithelial Lesions 05/2001
1	Paraganglioma (Paragangliomas) 02/2001
1	Febrile Neutropenia 01/2001
1	Ovarian Neoplasms (Ovarian Cancer) 11/2000
1	Peritoneal Neoplasms 08/2000
1	Transitional Cell Carcinoma 07/2000
1	Carcinoma (Carcinomatosis) 05/2000
1	Carcinogenesis 05/2000

Drug/Important Bio-Agent (IBA)

7	AnthracyclinesIBA 01/2009 - 12/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 07/2003
5	Docetaxel (Taxotere)FDA Link 01/2009 - 01/2001
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2009 - 12/2003
3	Melphalan (Alkeran)FDA LinkGeneric 03/2009 - 07/2003
3	Taxoids (Taxanes)IBA 01/2009 - 09/2008
2	Tumor Biomarkers (Tumor Markers)IBA 05/2008 - 07/2001
2	liposomal doxorubicin (Doxil)FDA Link 05/2005 - 11/2004
2	Antineoplastic Agents (Antineoplastics)IBA 05/2005 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 08/2001 - 05/2000
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 07/2001 - 11/2000
2	AntigensIBA 10/2000 - 03/2000
1	Glucose (Dextrose)FDA LinkGeneric 07/2012
1	CytokinesIBA 01/2012
1	ProdrugsIBA 01/2011
1	Imatinib Mesylate (Gleevec)FDA Link 01/2011
1	OligonucleotidesIBA 01/2011
1	Hormones (Hormone)IBA 01/2009
1	taxaneIBA 11/2008
1	Trastuzumab (Herceptin)FDA Link 11/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2008
1	SurvivinIBA 05/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2007
1	Epirubicin (Ellence)FDA LinkGeneric 07/2007
1	Fluorouracil (Carac)FDA LinkGeneric 07/2007
1	Coloring Agents (Dyes)IBA 03/2007
1	Liposomes (Liposome)IBA 11/2004
1	Cytostatic AgentsIBA 07/2003
1	Carcinoembryonic AntigenIBA 08/2001
1	tissue polypeptide specific antigenIBA 07/2001
1	Glucose Transporter Type 1IBA 07/2001
1	DNA (Deoxyribonucleic Acid)IBA 05/2001
1	fragile histidine triad proteinIBA 05/2001
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2001
1	ThymidineIBA 03/2001
1	Methionine (L-Methionine)FDA Link 03/2001
1	Capsules (Microcapsules)IBA 02/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2000
1	Estrogens (Estrogen)FDA Link 12/2000
1	EnzymesIBA 11/2000
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2000
1	AcidsIBA 10/2000
1	Peptides (Polypeptides)IBA 10/2000
1	MucinsIBA 10/2000
1	Monoclonal AntibodiesIBA 10/2000
1	AcetoneIBA 10/2000
1	Indicators and Reagents (Reagents)IBA 07/2000
1	fas Receptor (CD95 Antigen)IBA 03/2000
1	Formaldehyde (Formol)FDA Link 03/2000
1	LigandsIBA 03/2000

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2011 - 08/2000
6	Therapeutics 09/2012 - 05/2000
4	Adjuvant Chemotherapy 01/2009 - 07/2007
2	Autologous Transplantation 01/2013 - 11/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2010 - 11/2008
2	Surgical Amputation (Amputations) 05/2005 - 12/2003
2	Neoadjuvant Therapy 12/2003 - 07/2001
1	Tracheostomy 01/2022
1	Neck Dissection (Radical Neck Dissection) 12/2020
1	Aftercare (After-Treatment) 11/2008
1	Radiotherapy 07/2007
1	Mastectomy (Mammectomy) 09/2006